Pancreatic Cancer Research

ResearcherNanjing Drum Tower HospitalNo recent work listed

Hui Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0237-6138; OpenAlex author ID A5101522795. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper

Papers 3

  1. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma. First author DOI 10.1002/mc.23554↗
  2. Analysis of T-cell receptor repertoire in peripheral blood of patients with pancreatic cancer and other pancreatic diseases. Co-author DOI 10.1111/jcmm.16358↗
  3. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.628346↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yixuan Zhang · 3 shared papers, 2021–2023 · strength 0.38
  2. Shu Zhang · 3 shared papers, 2021–2023 · strength 0.38
  3. Xiaoping Zou · 3 shared papers, 2021–2023 · strength 0.38
  4. Ying Lv · 2 shared papers, 2021–2023 · strength 0.28
  5. Qiang Zhan · 1 shared paper, 2023 · strength 0.17
  6. Shanshan Shen · 1 shared paper, 2023 · strength 0.17
  7. Siqi Zhou · 1 shared paper, 2021 · strength 0.11
  8. Dongming Zhu · 1 shared paper, 2021 · strength 0.11
  9. Jie An Yang · 1 shared paper, 2021 · strength 0.11
  10. Xin Gao · 1 shared paper, 2021 · strength 0.11
  11. Lei Wang · 1 shared paper, 2021 · strength 0.10
  12. Jie Yang · 1 shared paper, 2021 · strength 0.10
  13. Ying Lv · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.